One-Stage vs Two-Stage Orchidopexy for Undescended Testicles
(GSLO Trial)
Trial Summary
What is the purpose of this trial?
This trial compares two surgical methods for moving undescended testicles in young boys. One method completes the surgery in a single procedure, while the other does it in multiple stages. The goal is to see which method better prevents testicle shrinkage.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment One-Stage vs Two-Stage Orchidopexy for Undescended Testicles?
Is the one-stage or two-stage orchidopexy for undescended testicles safe?
Both one-stage and two-stage orchidopexy procedures for undescended testicles have been studied for safety, with low rates of complications such as testicular atrophy (shrinkage) and testicular ascent (movement). The overall testicular atrophy rate was found to be 1.5%, and there was no significant difference in complications between open and laparoscopic approaches.12356
How does the One-Stage vs Two-Stage GSLO treatment for undescended testicles differ from other treatments?
The One-Stage and Two-Stage GSLO treatments for undescended testicles are unique because they use a minimally invasive laparoscopic technique that preserves the gubernaculum (a structure that helps guide the testicle into the scrotum), which may reduce the risk of testicular atrophy (shrinkage) and improve positioning. This approach contrasts with traditional methods that may involve more invasive surgery or do not focus on preserving the gubernaculum.12478
Research Team
Luis H Braga, M.D.
Principal Investigator
McMaster University
Eligibility Criteria
This trial is for boys aged 1-5 with undescended testicles located inside the abdomen, who haven't had previous laparoscopic surgery for this condition. The procedure will be done by specialized Pediatric Urologists.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either a one-stage or two-stage gubernaculum sparing laparoscopic orchidopexy (GSLO). The two-stage procedure involves an initial ligation of testicular vessels, followed by a second stage 3-6 months later for testis mobilization and fixation.
Follow-up
Participants are monitored for postoperative testicular atrophy and other outcomes.
Treatment Details
Interventions
- One-Stage GSLO Technique (Procedure)
- Two-Stage GSLO Technique (Procedure)
One-Stage GSLO Technique is already approved in Canada, Japan, China, Switzerland for the following indications:
- Undescended Testis (UDT)
- Cryptorchidism
- Undescended Testis (UDT)
- Cryptorchidism
- Undescended Testis (UDT)
- Cryptorchidism
- Undescended Testis (UDT)
- Cryptorchidism
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster University
Lead Sponsor
Evan Stein
McMaster University
Chief Medical Officer since 2015
MD, PhD
Sam
McMaster University
Chief Executive Officer since 2023
MBA from McMaster University
McMaster Surgical Associates
Collaborator